Membrane-type 4 matrix metalloproteinase promotes breast cancer growth and metastases

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Membrane-type matrix metalloproteinases (MT-MMPs) are a group of six membrane-associated proteases.
• While MT1-MMP's role in cancer is known, other MT-MMPs, like MT4-MMP, are less understood.

Purpose of the Study:

• To investigate the role of MT4-MMP in breast cancer progression.
• To determine if MT4-MMP protein levels correlate with breast cancer severity.

Main Methods:

• Immunohistochemistry to analyze MT4-MMP protein expression in human breast carcinomas and normal tissues.
• Quantitative reverse transcription-PCR (qRT-PCR) to assess MT4-MMP mRNA levels.
• Stable transfection of MT4-MMP cDNA into MDA-MB-231 cells and subsequent in vivo studies in RAG-1 immunodeficient mice.

Main Results:

• MT4-MMP protein is significantly upregulated in epithelial cancer cells of human breast carcinomas and in lymph node metastases compared to normal cells.
• MT4-MMP mRNA levels were similar between cancerous and normal breast tissues.
• In vivo, MT4-MMP overexpression accelerated primary tumor growth, increased blood vessel size within tumors, and promoted lung metastases.
• In vitro proliferation and invasion were not affected by MT4-MMP overexpression.

Conclusions:

• MT4-MMP protein upregulation, not mRNA, is linked to breast cancer progression.
• MT4-MMP overexpression promotes tumor growth, angiogenesis, and metastasis in vivo.
• MT4-MMP represents a potential therapeutic target for breast cancer treatment.